Primary hyperammonaemia: Current diagnostic and therapeutic strategies

Area of Science:

• Biochemistry
• Genetics
• Pediatrics
• Rare Diseases

Background:

• Primary hyperammonaemia results from defects in the urea cycle, essential for ammonia detoxification and arginine biosynthesis.
• Urea cycle disorders (UCDs) are rare genetic conditions impacting urea cycle enzymes or transporters, leading to ammonia accumulation.
• Clinical presentation varies, with neonatal hyperammonaemic encephalopathy posing risks of severe brain damage or death.

Purpose of the Study:

• To provide an overview of the clinical management of urea cycle disorders (UCDs).
• To raise awareness for UCDs as an important group of rare diseases.
• To emphasize the importance of early identification and effective treatment strategies.

Main Methods:

• Acute management involves ammonia detoxification via extracorporeal methods (e.g., haemodialysis) and nitrogen scavenger medications.
• Long-term management includes a carefully balanced low-protein diet with essential nutrient supplementation.
• Continued use of nitrogen scavengers is a key component of chronic UCD management.

Main Results:

• Early identification of UCDs is critical for initiating timely and effective treatment.
• Prompt management can mitigate the risk of severe neurological sequelae associated with hyperammonaemia.
• A multi-faceted approach combining dietary modifications and medical therapy is essential for UCD patients.

Conclusions:

• Effective clinical management of UCDs requires a comprehensive strategy addressing both acute and long-term needs.
• Awareness and understanding of UCDs are vital for healthcare professionals to ensure optimal patient care.
• Integrated management approaches are key to improving outcomes for individuals with these rare metabolic disorders.